- Open
- 1931.50
- High
- 1942.50
- Low
- 1900.00
- Close
- 1912.50
- Change
- -3.00 (-0.16%)
- Volume
- 1,974,698
⌘K
| 22 May 2026 | 10:30:28 | Q2 2026 Results Date Confirmed - 28 July 2026 |
| 20 May 2026 | 15:30:01 | Director/PDMR Shareholding |
| 19 May 2026 | 15:30:01 | Director/PDMR Shareholding |
| 18 May 2026 | 15:00:00 | Transaction in Own Shares |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc, previously known as GlaxoSmithKline plc, is a multinational biotechnology and pharmaceutical corporation based in London, England, with a worldwide presence.
| 22 May 2026 | 10:30:28 | Q2 2026 Results Date Confirmed - 28 July 2026 |
| 20 May 2026 | 15:30:01 | Director/PDMR Shareholding |
| 19 May 2026 | 15:30:01 | Director/PDMR Shareholding |
| 18 May 2026 | 15:00:00 | Transaction in Own Shares |
| 5 Mar 2026 | 2025 Annual Financial Report | |
| 27 Feb 2025 | 2024 Annual Financial Report | |
| 1 Mar 2024 | 2023 Annual Financial Report |
GSK plc, previously known as GlaxoSmithKline plc, is a multinational biotechnology and pharmaceutical corporation based in London, England, with a worldwide presence.
| 18 May 2026 |
| 07:00:09 |
| Japan MHLW approves Arexvy for adults 18-49 AIR |
| 18 May 2026 |
| 07:00:09 |
| Japan MHLW approves Arexvy for adults 18-49 AIR |
